Ed. note: Here is another installment from longtime reader Myron Martin. Myron has agreed to our trading restrictions (he won’t trade the stocks he mentions for three days), but we have not reviewed, approved or screened his stocks or ideas, and the opinions he expresses are solely his own. Myron’s past commentaries can be seen […]
Articles
- Most Relevant
- Most Recent
The “Trade War” is getting real, and the higher prices imposed by governments in China and the US. Tariffs are just import taxes, paid eventually by the customer, so they raise prices… which, our economist friends will tell us, suppresses demand… and since the higher price is going to a tax, not to a company, […]
Let’s start with the bad news… we got quarterly updates this week from Charlotte’s Web (CWEB.TO, CWBHF) and II-VI (IIVI), both stocks I’ve bought fairly recently (IIVI just a few weeks ago, CWEB a few months ago), and those are both in the red. Neither one hit a stop loss yet, but what did we […]
This is a little unusual, because typically I let investments percolate for a while before deciding whether or not they make sense. But today, I think the best idea for investing is one I wrote about just this week at StockGumshoe.com — Hanfeng Evergreen. In case you’re wondering about that title, Han is the ethnicity […]
I’ve been putting out my updated thoughts on each of our Irregulars spreadsheet companies (mostly past “Idea of the Month” stocks) over the last couple weeks, and now that I’m done looking at all of the “Speculations” on that list I thought I should combine them into one document to make it a bit easier […]
No, these bits won’t be about Melania’s kidney ailment nor yet about what Meghan wore for The Wedding. I wish them both luck – they’ll need it!. However, there continue to be developments on the medical and health-care fronts that may matter to us a good deal more than the doings of those ladies. […]
I’m still able to generate some enthusiasm about specific stocks that I think are appealing enough to buy at these prices… but I find it very hard to be optimistic in a macro sense right now, it really feels to me as though the market is whistling past the graveyard and being far too sanguine […]
This is a little unusual, because typically I let investments percolate for a while before deciding whether or not they make sense. But today, I think the best idea for investing is one I wrote about just this week at StockGumshoe.com — Hanfeng Evergreen. In case you’re wondering about that title, Han is the ethnicity […]
A hodgepodge of thoughts and comments to catch up with thoughts on a few companies that have reported quarterly results or had other meaningful news as I was on vacation — and a quick note on a small buy. First, I need to let you know that I bought a few JP Morgan warrants (JPM-WT) […]
I’ve invested in and written about quite a few Brazilian companies over the years, and I own a handful of such stocks today — so with the Brazilian market taking a hit this year, I thought I’d take a quick look at those holdings. There are two Brazilian companies that I’ve profiled as “Idea of […]
This month I have two stocks that are really catching my attention: one that I’ve held for many years and think is one of the most solid and steady companies you can buy, at a nice value right now; and one that caught my eye following a teaser writeup I did a couple weeks back, […]
Have you ever heard the quote, “nothing tastes as good as thin feels?” Such sayings have been attributed to waif model Kate Moss, plenty of her anorexic fans, and dozens of others in the perfection industry (including Stephen Covey), and I’ll confess that the sentiment has never resonated with me even a little bit (as […]
I’ve invested in and written about quite a few Brazilian companies over the years, and I own a handful of such stocks today — so with the Brazilian market taking a hit this year, I thought I’d take a quick look at those holdings. There are two Brazilian companies that I’ve profiled as “Idea of […]
I’ve invested in and written about quite a few Brazilian companies over the years, and I own a handful of such stocks today — so with the Brazilian market taking a hit this year, I thought I’d take a quick look at those holdings. There are two Brazilian companies that I’ve profiled as “Idea of […]
I’ve invested in and written about quite a few Brazilian companies over the years, and I own a handful of such stocks today — so with the Brazilian market taking a hit this year, I thought I’d take a quick look at those holdings. There are two Brazilian companies that I’ve profiled as “Idea of […]
I’ve invested in and written about quite a few Brazilian companies over the years, and I own a handful of such stocks today — so with the Brazilian market taking a hit this year, I thought I’d take a quick look at those holdings. There are two Brazilian companies that I’ve profiled as “Idea of […]
It’s been a heckuva week, eh? I have no idea whether this is really the “capitulation” washout that so many investing pundits have been looking for, or whether we’ll keep falling on Monday or will bounce back after the week ended so roughly, but I do have a couple thoughts to share with you about […]
Has anyone had any experience with Jack Carter’s, ”Colorado Trading Experiment” also called his ”Trend Point” program?
This is how ETF Trend Trading explains their offer: How to have Massive Profits from Exploiting Market Inefficiencies… With My New AAPL Signals System Any idea what he’s talking about? Thanks. Rm Keith
Hi. I’m a new Gumshoe joiner and wondered if anyone has information regarding the above. It is a software that needs to be installed on an MT4 platform and claims to accurately predict trend direction for the major currency pairs, across a number of timeframes
Mark Skousen has been pitching the “SS-4 Income Stream” hard for the last couple weeks, and I’ve gotten a lot of questions and we’ve had a lto of discussion on the site about it … so I thought we should dig in and see if we can get a definitive answer about which investment he’s […]
That’s our pitch today — that the new “themed” technology investments being teased by the Motley Foolians are as good as David Gardner’s push for AOL and Amazon.com back in the days before the Motley Fool published their current Stock Advisor newsletter. The ad letter actually comes in from a different Fool employee, Todd Etter, […]
This is the Friday File, our missive to our favorite members (yes, we mean “the people who pay us”), so we can be a bit more up front with you and not make you sit through the entire spiel (though we’ll give you a full spiel-look as well) … David Gardner is now aggressively touting […]
Note: This article was originally published as a Friday File for the Stock Gumshoe Irregulars on October 26. At that time I did not own shares personally, but I now do own shares and have an additional limit order in to buy more if the price drops. The ad has still been running recently, and […]
The folks at Phase 1 Investor, the “big ticket” newsletter from Stansberry & Associates currently helmed by Frank Curzio, tend to love teensy weensy biotech and mining stocks — so when the teaser from Curzio hit my inbox this week for a more traditional tech stock with a more reasonable market cap, I sat up […]
The Wealth Advisory is one of those “entry level” newsletters that pretty much all publishers put out — it costs less than a hundred bucks a year, and it gets you used to paying for financial analysis without feeling too much pain … sort of a gateway drug before you get pitched on the “hard […]
The folks at Hyperion Financial have a new China-focused newsletter that they’re promoting pretty actively now, which is certainly at least a little bit of a “contrarian” move — most of the China-focused newsletters have been pretty quiet lately, not having too much to brag about, and a few have even shut down entirely (notably […]
As promised, we’re following up with the rest of the picks that Stephen Leeb (sorry, Dr. Stephen Leeb) is pitching as his “MCR” Plan. If you missed our first entry as we began demystifying this particular ad, you can see it here — the short version is, he’s touting dividend paying stocks in the medical […]
Today I’m focusing on answering some questions from readers about a few stocks, some that I own and have suggested to Irregulars in the past, some that are new to me. As might not surprise you, much of this is about some of the royalty and streaming stocks, including one that several folks are whispering […]
I haven’t written about any teasers from Dr. Stephen Leeb lately, but this one caught my eye — he’s got not only a made up term for an investment (the “MCR Plan”), but also a made-up term for how you’ll profit from it (“Income Stacking”). So the great readers of Gumshoedom have asked for answers, […]
OK, so I was called away before we got through the rest of Mark Skousen’s ideas for profiting from the election (which he is convinced will bring a victory for Romney and stock market ebullience) — so let’s jump right in and finish sniffing out those picks, shall we? The first three were energy and […]
Peter Krauth has been pitching the idea of investing in preparation for “The Last Five Minutes” — which is basically a premise that we’re approaching the point where consumption and depletion of many easily economic commodities (meaning, they’re not too hard to find or expensive to produce) is reaching its last huge move upward, the […]
This one may not be entirely loaded with secret stocks, since I suspect quite a few ardent Gumshoe readers have already figured out who they’re talking about as “Steve Jobs’ Mentor” … and therefore figured out which company they’re teasing … but, well, I’m still getting a lot of questions every day on this one, […]
If you ever want a dose of optimism, just read through (or listen to) any of the ads for Breakthrough Technology Alert — Patrick Cox will have you swelling with rosy thoughts about a future without disease or hardship, with a nice dose of 1,000,000% returns thrown in … that, after all, is the raison […]
“The ‘unmistakable signal’ that could lead YOU to profits of 246%, 631%, even 1,425% “Only one in a thousand investors has even heard of it. But it’s delivered them an average return of 140% for more than ten years running. “And the signal just started flashing AGAIN — pointing them to a surging stock that […]
I do love it when newsletters are teasing themes that we’re familiar with (they tend to run in fads, just like everything else), and especially when they give specific dates by which you need to act in order to reap these fabulou rewards. Not that the dates always really mean anything — sometimes they’re predictions […]
This month I have two stocks that are really catching my attention: one that I’ve held for many years and think is one of the most solid and steady companies you can buy, at a nice value right now; and one that caught my eye following a teaser writeup I did a couple weeks back, […]
Frank Curzio is pitching this idea of “Eagle Diesel” to get subscribers for his Small Stock Specialist newsletter (published by Stansberry & Associates, used to be called Penny Stock Specialist). He used to focus solely on stocks that trade under $10 a share, but from what I can tell he has recently been expanding his […]
Those of you who’ve been around these parts know that I’m a sucker for relatively unknown foreign stocks — we’ve suggested a few of them in the past to the Irregulars, including some relatively hard-to-trade picks that I still like like Nagacorp in Cambodia and Lonrho in Africa, and we’ve uncovered many more from a […]
It’s been a few days since we covered a nice, long hyped up teaser from the Motley Fool Stock Advisor — though that’s also probably the newsletter that we’ve covered more than any other, given their popularity and their heavy marketing. So what are they promising this time around? “The talking heads on TV are […]